N

NOXXON Pharma

26 employees

TME Pharma develops biostable aptamers and substances based on mirror image nucleic acids.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

1998

Funding rounds raised

Total raised

$50M

from 16 investors over 16 rounds

N

NOXXON Pharma raised $1.4M on March 3, 2021

Investors: Kreos Capital

N

NOXXON Pharma raised $7M on November 16, 2018

Investors: Acuitas Investments, LLC

N

NOXXON Pharma raised $1.1M on May 2, 2017

Investors: Kreos Capital

N

NOXXON Pharma raised $40M on May 27, 2010

Investors: IBG Beteiligungsgesellschaft, TVM Life Science Management Inc, BMP Marketing, Sofinnova Partners, Seventure Partners and Andera Partners

N

NOXXON Pharma raised $50M on May 3, 2007

Investors: IBG Beteiligungsgesellschaft, TVM Life Science Management Inc, Andera Partners, Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG and Sofinnova Partners

N

NOXXON Pharma raised $17M on November 15, 2000

Investors: 2015 Excalibur Group. Reserved and Hanover Finance (New Zealand)

FAQ